Danske Bank A S Purchases New Position in Humana Inc. $HUM

Danske Bank A S purchased a new position in Humana Inc. (NYSE:HUM) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 61,897 shares of the insurance provider’s stock, valued at approximately $24,587,000. Danske Bank A S owned approximately 0.05% of Humana at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. Montag A & Associates Inc. raised its position in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares during the period. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana in the 4th quarter worth approximately $27,000. Trust Co. of Vermont bought a new position in shares of Humana during the 2nd quarter valued at approximately $28,000. Reflection Asset Management purchased a new stake in Humana during the 4th quarter valued at $29,000. Finally, Bogart Wealth LLC raised its holdings in Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after buying an additional 48 shares during the period. 92.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have commented on HUM. Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price objective for the company in a research note on Thursday, July 30th. UBS Group began coverage on shares of Humana in a research note on Thursday, July 30th. They issued a “buy” rating on the stock. Morgan Stanley upgraded shares of Humana from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $249.00 to $370.00 in a report on Tuesday, August 4th. JPMorgan Chase & Co. upped their price target on shares of Humana from $316.00 to $393.00 and gave the company a “neutral” rating in a report on Monday, August 10th. Finally, The Goldman Sachs Group upped their price target on shares of Humana from $158.00 to $195.00 and gave the company a “sell” rating in a report on Thursday, April 30th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $395.22.

Humana Stock Performance

Shares of Humana stock opened at $377.18 on Thursday. The stock’s fifty day moving average is $383.16 and its two-hundred day moving average is $279.59. The company has a market capitalization of $45.29 billion, a PE ratio of 35.68, a price-to-earnings-growth ratio of 2.18 and a beta of 0.72. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same quarter last year, the firm posted $6.27 earnings per share. The business’s revenue was up 26.2% compared to the same quarter last year. As a group, analysts expect that Humana Inc. will post 9.08 earnings per share for the current year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.